Corix Bioscience (Corix Bioscience) COGS-to-Revenue : 0.00 (As of Sep. 2017)

View and export this data going back to 2008. Start your Free Trial

What is Corix Bioscience COGS-to-Revenue?

Corix Bioscience's Cost of Goods Sold for the three months ended in Sep. 2017 was $0.00 Mil. Its Revenue for the three months ended in Sep. 2017 was $0.00 Mil.

Corix Bioscience's COGS to Revenue for the three months ended in Sep. 2017 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Corix Bioscience's Gross Margin % for the three months ended in Sep. 2017 was N/A%.

Corix Bioscience COGS-to-Revenue Historical Data

The historical data trend for Corix Bioscience's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corix Bioscience COGS-to-Revenue Chart

Corix Bioscience Annual Data

Trend

Jan09

Jan10

Jan11

Jan12

Jan13

Jan14

Jan15

Dec16

COGS-to-Revenue

Get a 7-Day Free Trial

Corix Bioscience Quarterly Data
	Oct12	Jan13	Apr13	Jul13	Oct13	Jan14	Apr14	Jul14	Oct14	Jan15	Apr15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17
COGS-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Corix Bioscience COGS-to-Revenue Calculation

Corix Bioscience's COGS to Revenue for the fiscal year that ended in Dec. 2016 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0.694
	=	0.00

Corix Bioscience's COGS to Revenue for the quarter that ended in Sep. 2017 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Corix Bioscience (GREY:CXBS) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Corix Bioscience's Gross Margin % for the three months ended in Sep. 2017 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Corix Bioscience COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Corix Bioscience's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Corix Bioscience (Corix Bioscience) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Corix Bioscience Inc (GREY:CXBS) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

18662 MaCaurther Boulevard, Suite 200, Irvine, CA, USA, 85085

Website

http://www.corixbioscience.com

Corix Bioscience Inc is a United States-based research and development firm of cannabidiol (CBD) products and treatments. It is engaged in the business of producing organic CBD oil used for medical applications and treatments. In addition, the group is also focused on the production of tetrahydrocannabivarin oil. The company is focused on operations in Oregon, California, and Nevada, United States.

Corix Bioscience (Corix Bioscience) Headlines

No Headlines